Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

Table 2. Results from randomized controlled trials comparing mycophenolate mofetil versus azathioprine for maintenance therapy in proliferative (class III–IV) lupus nephritis. AZA (120 mg/day ...

Results from randomized controlled trials comparing mycophenolate mofetil versus azathioprine for maintenance therapy in proliferative (class III–IV) lupus nephritis. AZA (120 mg/day ...

Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...

Objective Traditional initial treatment regimens for lupus nephritis (LN) used oral glucocorticoids (GC) in starting doses up to 1.0 mg/kg/day prednisone equivalent with or without a preceding ...

Originally approved in 2011 as an IV therapy for adults with SLE ... as the only biologic approved to treat SLE. Approval in lupus nephritis is expected to push the product above the $1 billion ...

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus ...

Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK® in autoimmune diseases Initial data for AlloNK® in ...

Fidelity Freedom Blend 2055 Cmgld Pool Q 23.96 Fidelity Freedom Blend 2055 Cmgld Pool R 23.96 Fidelity Freedom Blend 2055 Cmgld Pool S 23.97 Fidelity Freedom Blend 2055 Cmgld Pool T 23.98 Indices ...